1043 related articles for article (PubMed ID: 9274623)
21. S100-mediated signal transduction in the nervous system and neurological diseases.
Zimmer DB; Chaplin J; Baldwin A; Rast M
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):201-14. PubMed ID: 16171556
[TBL] [Abstract][Full Text] [Related]
22. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.
Fullen DR; Garrisi AJ; Sanders D; Thomas D
J Cutan Pathol; 2008 Nov; 35 Suppl 2():28-34. PubMed ID: 18201235
[TBL] [Abstract][Full Text] [Related]
23. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
24. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
25. Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma.
Nürnberg W; Tobias D; Otto F; Henz BM; Schadendorf D
J Pathol; 1999 Dec; 189(4):546-51. PubMed ID: 10629556
[TBL] [Abstract][Full Text] [Related]
26. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
Nakakuma H; Horikawa K; Kawaguchi T; Hidaka M; Nagakura S; Hirai S; Kageshita T; Ono T; Kagimoto T; Iwamori M
Jpn J Clin Oncol; 1992 Oct; 22(5):308-12. PubMed ID: 1469793
[TBL] [Abstract][Full Text] [Related]
27. Cadherin expression in melanocytic naevi and malignant melanomas.
Cowley GP; Smith ME
J Pathol; 1996 Jun; 179(2):183-7. PubMed ID: 8758211
[TBL] [Abstract][Full Text] [Related]
28. Expression of S100A2 and S100A6 in thyroid carcinomas.
Ito Y; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
Histopathology; 2005 May; 46(5):569-75. PubMed ID: 15842639
[TBL] [Abstract][Full Text] [Related]
29. Equine skin tumours in 20 horses resembling three variants of human melanocytic naevi.
Schöniger S; Summers BA
Vet Dermatol; 2009 Jun; 20(3):165-73. PubMed ID: 19374725
[TBL] [Abstract][Full Text] [Related]
30. Aberrant expression of S100A6 and matrix metalloproteinase 9, but not S100A2, S100A4, and S100A7, is associated with epidermal carcinogenesis.
Zhu L; Kohda F; Nakahara T; Chiba T; Tsuji G; Hachisuka J; Ito T; Tu Y; Moroi Y; Uchi H; Furue M
J Dermatol Sci; 2013 Dec; 72(3):311-9. PubMed ID: 23993025
[TBL] [Abstract][Full Text] [Related]
31. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
Lampert A; Thomine E; Lauret P; Hemet J
Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
[TBL] [Abstract][Full Text] [Related]
32. In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.
Bosserhoff AK; Moser M; Hein R; Landthaler M; Buettner R
J Pathol; 1999 Mar; 187(4):446-54. PubMed ID: 10398105
[TBL] [Abstract][Full Text] [Related]
33. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
Steuhl KP; Rohrbach JM; Knorr M
Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
[TBL] [Abstract][Full Text] [Related]
34. Histochemical characteristics of calcium binding S100 proteins and bone morphogenetic proteins in chondro-osseous tumors.
Muramatsu Y; Kamegai A; Shiba T; Shrestha P; Takai Y; Mori M; Ilg E; Schafer B; Heizmann C
Oncol Rep; 1997; 4(1):49-53. PubMed ID: 21590010
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical localization of thrombomodulin in normal human skin and skin tumours.
Jackson DE; Mitchell CA; Bird P; Salem HH; Hayman JA
J Pathol; 1995 Apr; 175(4):421-32. PubMed ID: 7790996
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma.
Komatsu K; Kobune-Fujiwara Y; Andoh A; Ishiguro S; Hunai H; Suzuki N; Kameyama M; Murata K; Miyoshi J; Akedo H; Tatsuta M; Nakamura H
Br J Cancer; 2000 Sep; 83(6):769-74. PubMed ID: 10952782
[TBL] [Abstract][Full Text] [Related]
37. Demonstration of heterodimer formation between S100B and S100A6 in the yeast two-hybrid system and human melanoma.
Yang Q; O'Hanlon D; Heizmann CW; Marks A
Exp Cell Res; 1999 Feb; 246(2):501-9. PubMed ID: 9925766
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
Väisänen A; Tuominen H; Kallioinen M; Turpeenniemi-Hujanen T
J Pathol; 1996 Nov; 180(3):283-9. PubMed ID: 8958806
[TBL] [Abstract][Full Text] [Related]
39. Expression of calcyclin in human melanocytic lesions.
Weterman MA; van Muijen GN; Bloemers HP; Ruiter DJ
Cancer Res; 1993 Dec; 53(24):6061-6. PubMed ID: 8261423
[TBL] [Abstract][Full Text] [Related]
40. Nevi, other than dysplastic and Spitz nevi.
Cochran AJ; Bailly C; Paul E; Dolbeau D
Semin Diagn Pathol; 1993 Feb; 10(1):3-17. PubMed ID: 8506415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]